(PCEC Rabies Vaccine)
a.Pre-exposure immunisation (preventative, prior to exposure):
Immunisation prior to possible infection with rabies, particularly for vets, veterinary medicine students, animal keepers, hunters, forestry workers, animal handlers, butchers, personnel in rabies research laboratories etc., or prior to visit to areas in which rabies is endemic (rabies infected areas).
b.Post-exposure treatment (after exposure):
Treatment after contact with animals which are rabid or suspected to be rabid, or after contact with an inoculated rabies carcass.
Influenza vaccine (surface antigen, inactivated, prepared in cell
(Live Attenuated Varicella Virus Vaccine)
The vaccination is recommended in the subject who has no history of Varicella and meets the below criteria:
1.High risk patients predisposed to varicella infection.
2.In acute lymphatic leukemia patients who meet all 4 below criteria:
2.1 Who are in remission from leukemia for at least 1 year.
2.2 Who have no detectable antibodies to Varicella zoster virus by FAMA.
2.3 Who have a positive response to mitogens in vitro.
2.4 Who have more than 700/mm3 lymphocytes.
3. Subjects who have closely come in touch with the unvaccinated high risk patients (e.g. patients, siblings or medical and paramedical attendants of the high risk patients).
4.Susceptible subjects in closed community (e.g. hospital ward or dormitory) such as healthcare workers.
5.Women who want to be prevented during pregnancy and the vaccination shall be done before pregnancy.
Freeze-dried Live Attenuated Hepatitis A Vaccine
1. Residents of communities with high endemic rates or recurrent outbreaks of Hepatitis A;
2. Travellers to countries where Hepatitis A is endemic, especially when the travel involves rural or primitive conditions;
3. Members of the armed forces, emergency relief workers and others likely to be posted abroad at short notice to areas with high rates of HAV infection;
4. Residents and staff of institutions where there is an ongoing problem with HAV transmission;
5. Inmates of correctional facilities in which there is an ongoing problem with HAV infection;
6. People with life style determined risks of infection, including those engaging in oral or intravenous illicit drug use in unsanitary conditions;
7. People with chronic liver disease who may be at increased risk of fulminant hepatits A;
8. Zoo-keepers, veterinarians and researchers who handle non-human primates;
(Japanese Encephalitis Vaccine, Live)
(Hepatitis B Vaccine (rDNA))
(Adsorbed Tetanus Vaccine)
Post exposure prophylaxis of tetanus: Tetanus infection may not confer immunity; therefore initiation or completion of active immunization is indicated at the time of recovery from this infection.
Neonatal tetanus prevention: If vaccination is required, tetanus toxoid can be used during pregnancy. Waiting until the second trimester to administer tetanus vaccine is a reasonable precaution for minimizing any concern regarding the theoretical possibility of adverse reactions.
Tetanus Prophylaxis in Wound Management: Tetanus toxoid can also be used prophylactically for wound management in persons 7 years of age and older.
Tetanus and Diphtheria vaccine
(adsorbed, reduced antigen content)
(Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed))
(Diphtheria and Tetanus Vaccine (Adsorbed, Reduced Antigen(s) Content))
(VACCINE AGAINST CHOLERA AND ETEC-DIARRHOEA)
Cholera: The vaccine is recommended for adults and children from 2 years of age who will be visiting areas with an ongoing or anticipated epidemic or who will be spending an extended period of time in areas in which cholera infection is a risk.
ETEC: The vaccine is recommended for adults and children from 2 years of age who will be visiting areas posing a great risk of diarrhoeal illness caused by enterotoxigenic Escherichia coli (ETEC).
(Tetanus vaccine, adsorbed)
• within the National Immunisation Programme:
- in case of contraindications for using: DTP, DT or Td vaccines,
- as a booster dose,
• in unvaccinated pregnant women,
• in active-passive prevention of tetanus in the case of contaminated wounds and at high risk of Clostridium tetani infection.